17th Annual World Preclinical Congress – Boston, MA (18th-21st June)

Dr Colin Brown will be attending the 17th Annual World Preclinical Congress between 18th and 21st June in Boston.

Dr Brown is the developer of the aProximateTM assay for measuring kidney transporter and nephrotoxicity licensed exclusively to Newcells Biotech.

The World Preclinical Congress is a key networking event focusing on the latest trends and technologies impacting drug discovery and translational research.

Dr Brown will be meeting with partners with research interests in renal, hepatic and GI drug transporters. If you are attending the World Preclinical Congress and would like to arrange a meeting with Dr Brown, then please let us know – https://newcellsbiotech.co.uk/collaborate/ 

 

You might also be interested in…
Blog

Looking Forward: A Year in Review

2018 has been a significant year for Newcells Biotech. We have secured substantial investment, launched new, ground-breaking products, attended global events and expanded our every growing team.   Here are some of our defining moments

Event

Newcells Head to Boston

International Trade Mission – December 2018  Newcells Biotech CEO, Dr Mike Nicholds, and CSO, Prof Lyle Armstrong, are delighted to be taking part in a global trade mission hosted by the Department for International Trade and partially funded by the Northern Powerhouse. Dr Nicholds and Prof Armstrong will travel to Greater

Blog

ESTIV 2018 International Congress

Congress Round-Up The International Congress on in vitro Toxicology (ESTIV2018) organised by the European Society of Toxicology was held in Berlin this October 2018.  This year marks its 20th meeting, with the general theme of new approach methodologies